Expert Discusses Best Practices for Managing Breast Cancer–Related Toxicities
March 14th 2022Charles L. Loprinzi, MD, discusses the efficacy of agents like gabapentin and olanzapine to combat breast cancer treatment-related pains and speaks to the future of nonestrogenic toxicity management within this space.
Bioimpedance Spectroscopy Is a Better Predictor of Chronic Lymphedema Vs Tape Measurement
February 6th 2022Patients who underwent surveillance with bioimpedance spectroscopy were less likely to develop chronic breast cancer–related lymphedema compared with patients who were assessed with tape measure.
Forgoing Select Lymph Node Dissection Linked With Superior Outcomes in Early-Stage Breast Cancer
December 28th 2021Updates from the ongoing INSEMA trial suggest that patients with early-stage breast cancer maintain superior quality of life by forgoing sentinel lymph node biopsy and axillary lymph node dissection.
Palbociclib Shows Clinical Benefit in Black and Hispanic Patients with HR+ Breast Cancer
December 9th 2021Findings from a pooled efficacy and safety analysis support the use of palbociclib plus endocrine therapy in patients who are Black or Hispanic with hormone receptor–positive, HER2-negative breast cancer.